Clinical Trials › NCT03535298
Active, Not RecruitingPhase 4
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Sponsored by The Cleveland Clinic
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 800
Target enrollment
8
U.S. states
Jan 2019
Start date
Jul 2027
Expected completion
Interventions / Treatments
Early Highly Effective Therapies GroupEscalation Therapies Group
Conditions studied
Multiple Sclerosis, Relapsing-Remitting
Participating MS centers on MS Buddy (11)
Mayo Clinic Center for MS and Autoimmune Neurology
Rochester, MN
Rochester, MN
University of Minnesota Multiple Sclerosis Center
Minneapolis, MN
Minneapolis, MN
UVA Multiple Sclerosis and Clinical Neuroimmunology Center
Charlottesville, VA
Charlottesville, VA
Mellen Center for MS Treatment & Research
Cleveland, OH
Cleveland, OH
The Waddell Center for Multiple Sclerosis
Cincinnati, OH
Cincinnati, OH
OhioHealth Multiple Sclerosis Center
Columbus, OH
Columbus, OH
Jacobs MS Center for Treatment and Research
Buffalo, NY
Buffalo, NY
Rochester Multiple Sclerosis Center
Rochester, NY
Rochester, NY
MS centers in Ohio
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Ohio centersMore Phase 4 trials
Browse all Phase 4 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
